Sign up to save your podcasts
Or
Share Talking the Cure: Discussing venture capital in the life sciences and health care sector in Germany
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Talking the Cure: Discussing venture capital in the life sciences and health care sector in Germany
In this episode, our partners Jörg Schickert and Nikolas Zirngibl talk with Jörn Bungartz, an adviser in the digital health sector, about opportunities and barriers for venture capital in the life sciences and health care industry in Germany.
You can find additional thought leadership and information regarding venture capital in the life sciences and health care industry on HL Engage.
If you are interested in more information all around Life Sciences and Health Care, follow us on LinkedIn and Twitter.
View all episodes
By Hogan LovellsIn this episode, our partners Jörg Schickert and Nikolas Zirngibl talk with Jörn Bungartz, an adviser in the digital health sector, about opportunities and barriers for venture capital in the life sciences and health care industry in Germany.
You can find additional thought leadership and information regarding venture capital in the life sciences and health care industry on HL Engage.
If you are interested in more information all around Life Sciences and Health Care, follow us on LinkedIn and Twitter.